Nova EYE Medical Ltd (EYE) - Net Assets

Latest as of June 2026: AU$14.28 Million AUD ≈ $10.10 Million USD

Based on the latest financial reports, Nova EYE Medical Ltd (EYE) has net assets worth AU$14.28 Million AUD (≈ $10.10 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$21.59 Million ≈ $15.27 Million USD) and total liabilities (AU$7.31 Million ≈ $5.17 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EYE capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$14.28 Million
% of Total Assets 66.12%
Annual Growth Rate 3.74%
5-Year Change -53.04%
10-Year Change -74.93%
Growth Volatility 618.67

Nova EYE Medical Ltd - Net Assets Trend (1989–2026)

This chart illustrates how Nova EYE Medical Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of Nova EYE Medical Ltd.

Annual Net Assets for Nova EYE Medical Ltd (1989–2026)

The table below shows the annual net assets of Nova EYE Medical Ltd from 1989 to 2026. Also explore Nova EYE Medical Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2026-06-30 AU$14.28 Million
≈ $10.10 Million		 -24.74%
2025-06-30 AU$18.97 Million
≈ $13.42 Million		 -11.08%
2024-06-30 AU$21.33 Million
≈ $15.09 Million		 -8.02%
2023-06-30 AU$23.19 Million
≈ $16.41 Million		 -23.71%
2022-06-30 AU$30.40 Million
≈ $21.51 Million		 -13.97%
2021-06-30 AU$35.34 Million
≈ $25.00 Million		 -64.87%
2020-06-30 AU$100.59 Million
≈ $71.17 Million		 +46.21%
2019-06-30 AU$68.80 Million
≈ $48.68 Million		 -6.07%
2018-06-30 AU$73.24 Million
≈ $51.82 Million		 +28.65%
2017-06-30 AU$56.93 Million
≈ $40.28 Million		 +17.98%
2016-06-30 AU$48.26 Million
≈ $34.14 Million		 +21.27%
2015-06-30 AU$39.79 Million
≈ $28.16 Million		 +7.70%
2014-06-30 AU$36.95 Million
≈ $26.14 Million		 +19.85%
2013-06-30 AU$30.83 Million
≈ $21.81 Million		 -3.83%
2012-06-30 AU$32.06 Million
≈ $22.68 Million		 +5.73%
2011-06-30 AU$30.32 Million
≈ $21.45 Million		 -8.63%
2010-06-30 AU$33.19 Million
≈ $23.48 Million		 +10.44%
2009-06-30 AU$30.05 Million
≈ $21.26 Million		 -37.32%
2008-06-30 AU$47.94 Million
≈ $33.92 Million		 +10.51%
2007-06-30 AU$43.38 Million
≈ $30.69 Million		 +23.44%
2006-06-30 AU$35.14 Million
≈ $24.87 Million		 +21.23%
2005-06-30 AU$28.99 Million
≈ $20.51 Million		 -4.88%
2004-06-30 AU$30.48 Million
≈ $21.57 Million		 -0.37%
2003-06-30 AU$30.59 Million
≈ $21.64 Million		 -0.70%
2002-06-30 AU$30.81 Million
≈ $21.80 Million		 +3800.18%
2001-06-30 AU$789.86K
≈ $558.88K		 +137.08%
2000-06-30 AU$333.16K
≈ $235.73K		 -35.81%
1999-06-30 AU$519.02K
≈ $367.24K		 -46.56%
1998-06-30 AU$971.14K
≈ $687.14K		 -40.84%
1997-06-30 AU$1.64 Million
≈ $1.16 Million		 -4.30%
1996-06-30 AU$1.72 Million
≈ $1.21 Million		 +42.46%
1995-06-30 AU$1.20 Million
≈ $851.91K		 +330.00%
1994-06-30 AU$280.00K
≈ $198.12K		 -42.39%
1993-06-30 AU$486.00K
≈ $343.88K		 -34.41%
1992-06-30 AU$741.00K
≈ $524.30K		 -32.39%
1991-06-30 AU$1.10 Million
≈ $775.49K		 +18.10%
1990-06-30 AU$928.00K
≈ $656.62K		 -74.71%
1989-06-30 AU$3.67 Million
≈ $2.60 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Nova EYE Medical Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 2813900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2026)

Component Amount Percentage
Common Stock AU$59.10 Million 414.03%
Other Comprehensive Income AU$-749.00K -5.25%
Total Equity AU$14.28 Million 100.00%

Nova EYE Medical Ltd Competitors by Market Cap

The table below lists competitors of Nova EYE Medical Ltd ranked by their market capitalization.

Company Market Cap
Camellia Metal Co Ltd
TWO:2064
 $26.22 Million
Bonasudden Holding AB
ST:BONAS
 $26.22 Million
Hansol Pns
KO:010420
 $26.22 Million
Sangji Caelum Inc
KQ:042940
 $26.24 Million
Renovaro Biosciences Inc
NASDAQ:RENB
 $26.19 Million
Hilbert Group AB Series B
ST:HILB-B
 $26.19 Million
Thai O.P.P. Public Company Limited
BK:TOPP
 $26.18 Million
CompuLab Ltd
TA:CLAB
 $26.17 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nova EYE Medical Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2025 to 2026, total equity changed from 18,967,000 to 14,275,000, a change of -4,692,000 (-24.7%).
  • Net loss of 4,333,000 reduced equity.
  • Other comprehensive income decreased equity by 519,000.
  • Other factors increased equity by 160,000.

Equity Change Factors (2025 to 2026)

Factor Impact Contribution
Net Income AU$-4.33 Million -30.35%
Other Comprehensive Income AU$-519.00K -3.64%
Other Changes AU$160.00K +1.12%
Total Change AU$- -24.74%

Book Value vs Market Value Analysis

This analysis compares Nova EYE Medical Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.59x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 5.09x to 2.59x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1989-06-30 AU$0.03 AU$0.13 x
1990-06-30 AU$0.01 AU$0.13 x
1991-06-30 AU$1.19 AU$0.13 x
1992-06-30 AU$0.80 AU$0.13 x
1993-06-30 AU$0.51 AU$0.13 x
1994-06-30 AU$0.29 AU$0.13 x
1995-06-30 AU$0.98 AU$0.13 x
1996-06-30 AU$0.91 AU$0.13 x
1997-06-30 AU$0.67 AU$0.13 x
1998-06-30 AU$0.32 AU$0.13 x
1999-06-30 AU$0.17 AU$0.13 x
2000-06-30 AU$0.12 AU$0.13 x
2001-06-30 AU$0.14 AU$0.13 x
2002-06-30 AU$0.50 AU$0.13 x
2003-06-30 AU$0.46 AU$0.13 x
2004-06-30 AU$0.46 AU$0.13 x
2005-06-30 AU$0.44 AU$0.13 x
2006-06-30 AU$0.51 AU$0.13 x
2007-06-30 AU$0.59 AU$0.13 x
2008-06-30 AU$0.64 AU$0.13 x
2009-06-30 AU$0.39 AU$0.13 x
2010-06-30 AU$0.39 AU$0.13 x
2011-06-30 AU$0.36 AU$0.13 x
2012-06-30 AU$0.38 AU$0.13 x
2013-06-30 AU$0.36 AU$0.13 x
2014-06-30 AU$0.34 AU$0.13 x
2015-06-30 AU$0.37 AU$0.13 x
2016-06-30 AU$0.44 AU$0.13 x
2017-06-30 AU$0.48 AU$0.13 x
2018-06-30 AU$0.55 AU$0.13 x
2019-06-30 AU$0.47 AU$0.13 x
2020-06-30 AU$0.68 AU$0.13 x
2021-06-30 AU$0.24 AU$0.13 x
2022-06-30 AU$0.20 AU$0.13 x
2023-06-30 AU$0.14 AU$0.13 x
2024-06-30 AU$0.10 AU$0.13 x
2025-06-30 AU$0.08 AU$0.13 x
2026-06-30 AU$0.05 AU$0.13 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nova EYE Medical Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -30.35%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -12.43%
  • • Asset Turnover: 1.62x
  • • Equity Multiplier: 1.51x
  • Recent ROE (-30.35%) is above the historical average (-41.75%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1989 -360.83% -1168.49% 0.29x 1.06x AU$-13.61 Million
1990 -295.37% -387.15% 0.51x 1.50x AU$-2.83 Million
1991 -29.47% -95.85% 0.28x 1.09x AU$-432.60K
1992 -72.20% -300.56% 0.21x 1.14x AU$-609.10K
1993 -92.18% -567.09% 0.14x 1.12x AU$-496.60K
1994 -73.57% -176.07% 0.38x 1.09x AU$-234.00K
1995 10.38% 1785.71% 0.01x 1.02x AU$4.60K
1996 -8.03% -1828.80% 0.00x 1.03x AU$-309.31K
1997 -16.39% -263.73% 0.06x 1.06x AU$-433.15K
1998 -68.99% 0.00% 0.00x 1.05x AU$-767.11K
1999 -140.27% 0.00% 0.00x 1.09x AU$-779.90K
2000 -110.46% 0.00% 0.00x 1.60x AU$-401.32K
2001 -58.49% -288750.00% 0.00x 1.45x AU$-540.99K
2002 -0.54% -0.61% 0.71x 1.26x AU$-3.25 Million
2003 5.34% 6.29% 0.70x 1.21x AU$-1.43 Million
2004 -0.68% -0.84% 0.64x 1.26x AU$-3.25 Million
2005 -3.80% -4.09% 0.69x 1.35x AU$-4.00 Million
2006 10.51% 10.65% 0.75x 1.32x AU$178.60K
2007 9.86% 9.38% 0.71x 1.47x AU$-58.90K
2008 9.94% 9.27% 0.71x 1.51x AU$-28.10K
2009 -75.79% -38.17% 1.16x 1.71x AU$-25.60 Million
2010 11.56% 7.87% 0.94x 1.56x AU$516.40K
2011 -2.35% -1.65% 0.89x 1.60x AU$-3.73 Million
2012 2.87% 1.94% 1.06x 1.40x AU$-2.29 Million
2013 -2.65% -1.89% 0.91x 1.54x AU$-3.90 Million
2014 2.13% 1.45% 1.00x 1.47x AU$-2.91 Million
2015 4.22% 2.68% 1.06x 1.48x AU$-2.30 Million
2016 6.27% 4.15% 1.01x 1.49x AU$-1.80 Million
2017 -1.57% -1.24% 0.83x 1.52x AU$-6.59 Million
2018 -6.93% -6.39% 0.77x 1.41x AU$-12.40 Million
2019 -9.68% -41.27% 0.16x 1.45x AU$-13.54 Million
2020 -6.95% -54.75% 0.11x 1.16x AU$-17.05 Million
2021 -12.33% -32.52% 0.32x 1.19x AU$-7.89 Million
2022 -24.66% -56.03% 0.37x 1.20x AU$-10.54 Million
2023 -65.94% -89.83% 0.56x 1.31x AU$-17.61 Million
2024 -41.21% -37.68% 0.78x 1.40x AU$-10.92 Million
2025 -47.76% -30.95% 1.10x 1.40x AU$-10.96 Million
2026 -30.35% -12.43% 1.62x 1.51x AU$-5.76 Million

Industry Comparison

This section compares Nova EYE Medical Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $73,526,976
  • Average return on equity (ROE) among peers: -54.60%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Nova EYE Medical Ltd (EYE) AU$14.28 Million -360.83% 0.51x $26.20 Million
4DMEDICAL Ltd (4DX) $64.24 Million -46.81% 0.48x $1.62 Billion
Adherium Ltd (ADR) $3.50 Million -3.95% 0.04x $3.18 Million
Aroa Biosurgery Ltd (ARX) $10.16 Million 0.00% 0.22x $128.81 Million
Atomo Diagnostics Ltd (AT1) $-5.47 Million 0.00% 0.00x $10.85 Million
Avita Medical Inc (AVH) $11.15 Million -79.70% 0.17x $188.51 Million
Anteris Technologies Global Corp (AVR) $13.22 Million -335.46% 0.78x $772.30 Million
Control Bionics Ltd (CBL) $7.12 Million -79.13% 0.22x $22.29 Million
Cardiex Ltd (CDX) $5.96 Million -63.62% 0.33x $13.23 Million
Compumedics Ltd (CMP) $14.60 Million 22.42% 0.79x $33.92 Million
Cochlear Ltd (COH) $610.80 Million 40.24% 0.89x $6.53 Billion

About Nova EYE Medical Ltd

AU:EYE Australia Medical Devices
Market Cap
$26.20 Million
AU$37.03 Million AUD
Market Cap Rank
#24309 Global
#969 in Australia
Share Price
AU$0.13
Change (1 day)
-3.70%
52-Week Range
AU$0.10 - AU$0.20
All Time High
AU$0.46
Categories
Companies in Australia Medical Devices
About

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company operates through Glaucoma Surgical Devices and AlphaRET segments. It offers 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degener… Read more